Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke
- PMID: 11872885
- DOI: 10.1161/hs0302.104168
Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke
Abstract
Background and purpose: Intravenous heparin therapy is often used in patients presenting with transient ischemic attack (TIA) or stroke as either bridging therapy for anticoagulation with warfarin or primary therapy in suspected intracranial arterial dissection, crescendo TIAs, or suspected hypercoagulable states. We attempted to validate the use of a weight-based nomogram for heparin-adjusted therapy during hospital admission of patients with TIA or stroke.
Methods: A prospective, single-blinded, randomized, clinical trial was undertaken to compare the use of a specially designed, weight-based heparin nomogram against the traditional method of physician-ordered heparin therapy for patients admitted with TIA or stroke. The trial was not designed to examine the efficacy of heparin therapy but to examine the use of the nomogram for labor requirements, costs of monitoring, safety, length of heparin therapy, and user-friendliness.
Results: Pretreatment clinical factors were comparable between those randomized to use of the nomogram (n=101) and to usual care (n=105). Nomogram patients had a significantly lower first activated partial thromboplastin time than nonnomogram patients (60.6 +/- 16.8 versus 69.8 +/- 28.7 seconds). Patients treated by nomogram achieved a therapeutic range of anticoagulation sooner than nonnomogram patients (13.4 +/- 17.0 versus 17.9 +/- 14.1 hours). The fraction of time during which anticoagulation was therapeutic was significantly greater in patients on nomogram therapy (74 +/- 25% versus 67 +/- 26%). Nomogram patients also had significantly fewer supratherapeutic coagulation results, significantly fewer dose adjustment mistakes, significantly fewer calls to house staff regarding anticoagulation, and significantly fewer total complications than nonnomogram patients. The times required for discontinuation of heparin and discharge from hospital were not significantly different. A survey of house staff and nursing staff showed a preference for nomogram use.
Conclusions: The heparin nomogram is a user-friendly method of maintaining heparin infusions and is associated with improved anticoagulation measures, fewer total complications related to heparin therapy, fewer mistakes in heparin dosage adjustment, and decreased labor on the part of house staff and nursing staff.
Comment in
-
Do we really need a better way to give heparin in acute cerebral ischemia?Stroke. 2002 Mar;33(3):659-60. Stroke. 2002. PMID: 11872882 No abstract available.
Similar articles
-
The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality.Blood Coagul Fibrinolysis. 2003 Jul;14(5):463-8. doi: 10.1097/00001721-200307000-00006. Blood Coagul Fibrinolysis. 2003. PMID: 12851532 Clinical Trial.
-
Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.Cerebrovasc Dis. 2008;26(2):171-7. doi: 10.1159/000145324. Epub 2008 Jul 15. Cerebrovasc Dis. 2008. PMID: 18628615 Clinical Trial.
-
Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients.Ther Drug Monit. 2015 Feb;37(1):33-9. doi: 10.1097/FTD.0000000000000099. Ther Drug Monit. 2015. PMID: 24831654
-
Rapid heparin anticoagulation: use of a weight-based nomogram.Am Fam Physician. 1996 Dec;54(8):2517-21. Am Fam Physician. 1996. PMID: 8961850 Review.
-
Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.Thromb Haemost. 2000 Jul;84(1):22-6. Thromb Haemost. 2000. PMID: 10928464 Review.
Cited by
-
Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.Hosp Pharm. 2016 Sep;51(8):656-661. doi: 10.1310/hpj5108-656. Hosp Pharm. 2016. PMID: 27698506 Free PMC article.
-
Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012 Feb;141(2 Suppl):e152S-e184S. doi: 10.1378/chest.11-2295. Chest. 2012. PMID: 22315259 Free PMC article. Review.
-
Need for Continued Use of Anticoagulants After Intracerebral Hemorrhage.Curr Treat Options Cardiovasc Med. 2003 Jul;5(3):201-209. doi: 10.1007/s11936-003-0004-1. Curr Treat Options Cardiovasc Med. 2003. PMID: 12777198
-
Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients.Br J Haematol. 2011 Aug;154(3):378-86. doi: 10.1111/j.1365-2141.2011.08775.x. Epub 2011 Jun 14. Br J Haematol. 2011. PMID: 21671895 Free PMC article. Clinical Trial.
-
Optimizing the Dosing of Heparin for Therapeutic Anticoagulation in Neurocritical Care Patients at High Risk of Bleeding: Report on a Quality Improvement Initiative.J Pharm Technol. 2025 May 24:87551225251343558. doi: 10.1177/87551225251343558. Online ahead of print. J Pharm Technol. 2025. PMID: 40421164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical